Cargando…

Immunomodulation in COVID-19

Detalles Bibliográficos
Autores principales:	Ingraham, Nicholas E, Lotfi-Emran, Sahar, Thielen, Beth K, Techar, Kristina, Morris, Rachel S, Holtan, Shernan G, Dudley, R Adams, Tignanelli, Christopher J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198187/ https://www.ncbi.nlm.nih.gov/pubmed/32380023 http://dx.doi.org/10.1016/S2213-2600(20)30226-5

Ejemplares similares

Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles
por: Lusczek, Elizabeth R., et al.
Publicado: (2021)

Proteomic pathways associated with developing severe disease for patients with COVID-19: A biologic analysis of data from two multicenter randomized controlled trials encompassing 13 U.S. hospitals
por: Samorodnitsky, Sarah, et al.
Publicado: (2023)

Racial and Ethnic Disparities in Hospital Admissions from COVID-19: Determining the Impact of Neighborhood Deprivation and Primary Language
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Fact Versus Science Fiction: Fighting Coronavirus Disease 2019 Requires the Wisdom to Know the Difference
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Graft-versus-host disease: teaching old drugs new tricks at less cost
por: Farhan, Shatha, et al.
Publicado: (2023)

We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity
por: Dutta, Nirjhar, et al.
Publicado: (2021)

Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies
por: Castro-Pearson, Sandra, et al.
Publicado: (2023)

Ayurveda Rasayana as antivirals and immunomodulators: potential applications in COVID-19
por: Singh, Rajeshwari, et al.
Publicado: (2021)

Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host Disease
por: Watson, Allison P., et al.
Publicado: (2018)

Antihypertensive drugs and risk of COVID-19?
por: Tignanelli, Christopher J, et al.
Publicado: (2020)

Developing A Baseline Metabolomic Signature Associated with COVID-19 Severity: Insights from Prospective Trials Encompassing 13 U.S. Centers
por: Yang, Kaifeng, et al.
Publicado: (2023)

Effect of COVID-19 precautions on the gut microbiota and nosocomial infections
por: Rashidi, Armin, et al.
Publicado: (2021)

COVID-19 and gut immunomodulation
por: Roy, Koushik, et al.
Publicado: (2021)

Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2015)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

Immunomodulation and immunotherapeutics of COVID-19
por: Garg, Sourbh Suren, et al.
Publicado: (2021)

Do Cancer and Cancer Treatments Accelerate Aging?
por: Bhatia, Roma, et al.
Publicado: (2022)

Perspectives of cancer patients and their health during the COVID-19 pandemic
por: Lou, Emil, et al.
Publicado: (2020)

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma
por: Holtan, Shernan G., et al.
Publicado: (2011)

Temporal variation in oral microbiome composition of patients undergoing autologous hematopoietic cell transplantation with keratinocyte growth factor
por: Bohn, Bruno, et al.
Publicado: (2023)

Deploying Medical Students to Combat Misinformation During the COVID-19 Pandemic
por: Quadri, Nasreen S., et al.
Publicado: (2020)

Immunopathogenesis of COVID-19 and early immunomodulators
por: Lee, Kyung-Yil, et al.
Publicado: (2020)

Cytokine Storm and Immunomodulation in COVID-19
por: Rangappa, Pradeep
Publicado: (2021)

Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021)

Fetal Sex-Based Differences in Maternal Hormones, Angiogenic Factors, and Immune Mediators During Pregnancy and the Postpartum Period
por: Enninga, Elizabeth Ann L, et al.
Publicado: (2015)

Predictors of Postacute Sequelae of COVID-19 Development and Rehabilitation: A Retrospective Study
por: Abdelwahab, Nermine, et al.
Publicado: (2022)

Predictors of discharge disposition and mortality following hospitalization with SARS-CoV-2 infection
por: Ikramuddin, Farha, et al.
Publicado: (2023)

Safety of an immunomodulator Mycobacterium w in COVID-19
por: Sehgal, Inderpaul Singh, et al.
Publicado: (2020)

Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
por: Mauvais-Jarvis, Franck, et al.
Publicado: (2020)

Combining Antivirals and Immunomodulators to Fight COVID-19
por: Feuillet, Vincent, et al.
Publicado: (2021)

COVID-19 and immunomodulator/immunosuppressant use in dermatology
por: Price, Kyla N., et al.
Publicado: (2020)

Immunomodulation and COVID-19: Is There a Winning Combination?
por: Samavedam, Srinivas
Publicado: (2020)

A 12-hospital prospective evaluation of a clinical decision support prognostic algorithm based on logistic regression as a form of machine learning to facilitate decision making for patients with suspected COVID-19
por: Lupei, Monica I., et al.
Publicado: (2022)

Responding to COVID-19 Through Interhospital Resource Coordination: A Mixed-Methods Evaluation
por: Usher, Michael G., et al.
Publicado: (2022)

75200 Fecal Microbiota Transplantation to Prevent Infections in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Placebo-Controlled Phase 2 Clinical Trial
por: Ebadi, Armin Rashidiryam, et al.
Publicado: (2021)

Fecal β-glucuronidase activity differs between hematopoietic cell and kidney transplantation and a possible mechanism for disparate dose requirements
por: Khan, Mohammad Haneef, et al.
Publicado: (2022)

Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review
por: Ingraham, Nicholas E., et al.
Publicado: (2020)

Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study
por: Holtan, Shernan G., et al.
Publicado: (2022)

Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review
por: Holtan, Shernan G., et al.
Publicado: (2022)

Correction to: Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review
por: Holtan, Shernan G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6dpa0u6jiiugj9fqpvt2j9mv4m